N Aiyar

452 total citations
10 papers, 371 citations indexed

About

N Aiyar is a scholar working on Pharmacology, Social Psychology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N Aiyar has authored 10 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Social Psychology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N Aiyar's work include Neuroendocrine regulation and behavior (3 papers), Electrolyte and hormonal disorders (3 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). N Aiyar is often cited by papers focused on Neuroendocrine regulation and behavior (3 papers), Electrolyte and hormonal disorders (3 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). N Aiyar collaborates with scholars based in United States and United Kingdom. N Aiyar's co-authors include P Nambi, F L Stassen, Weike Bao, Stephen A. Douglas, Paul G. Green, David J. Behm, Deborah J. Walker, David G. Johns, Dion A. Daniels and Andrew J. Brown and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Molecular Pharmacology.

In The Last Decade

N Aiyar

10 papers receiving 362 citations

Peers

N Aiyar

PHARM

MB

CMN

EDM

SURGE

Kirstin Reinecke Germany

Sergio Arrabal Spain

Romain Gerbier France

Mária Szekeres Hungary

N J Welsh United Kingdom

Dhanush Haspula United States

Karin Osibow Austria

Mohammed Bensaïd France

Panayiota Papadopoulos Canada

Masaru Doshi Japan

Kirstin Reinecke Germany

N Aiyar

157 ×0.8

PHARM

137 ×1.1

MB

95 ×1.0

CMN

36 ×0.4

EDM

41 ×0.5

SURGE

Citations per year, relative to N Aiyar N Aiyar (= 1×) peers Kirstin Reinecke

Countries citing papers authored by N Aiyar

Since Specialization

Citations

This map shows the geographic impact of N Aiyar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Aiyar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Aiyar more than expected).

Fields of papers citing papers by N Aiyar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Aiyar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Aiyar. The network helps show where N Aiyar may publish in the future.

Co-authorship network of co-authors of N Aiyar

This figure shows the co-authorship network connecting the top 25 collaborators of N Aiyar. A scholar is included among the top collaborators of N Aiyar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Aiyar. N Aiyar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Aiyar, N, et al.. (2010). GSK1562590, a slowly dissociating urotensin‐II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo. British Journal of Pharmacology. 161(1). 207–228. 22 indexed citations

2.

Mosenkis, Ari, et al.. (2010). Renal impairment, hypertension and plasma urotensin II. Nephrology Dialysis Transplantation. 26(2). 609–614. 14 indexed citations

3.

Johns, David G., David J. Behm, Deborah J. Walker, et al.. (2007). The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. British Journal of Pharmacology. 152(5). 825–831. 198 indexed citations

4.

Nambi, P, M Pullen, D. Saunders, et al.. (1996). Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors.. Journal of Pharmacology and Experimental Therapeutics. 277(3). 1567–1571. 8 indexed citations

5.

Edwards, Richard M., E J Stack, Edwin F. Weidley, et al.. (1992). Characterization of renal angiotensin II receptors using subtype selective antagonists.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 933–938. 36 indexed citations

6.

Edwards, Richard M., N Aiyar, Eliot H. Ohlstein, et al.. (1992). Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.. Journal of Pharmacology and Experimental Therapeutics. 260(1). 175–181. 14 indexed citations

7.

Stassen, F L, Delf Schmidt, Maryte Papadopoulos, et al.. (1988). Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.. Molecular Pharmacology. 33(2). 218–224. 20 indexed citations

8.

Stassen, F L, Dulcie B. Schmidt, P Nambi, et al.. (1987). A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.. Molecular Pharmacology. 31(3). 267–272. 1 indexed citations

9.

Aiyar, N, et al.. (1987). Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line.. Molecular Pharmacology. 31(2). 180–184. 47 indexed citations

10.

Stassen, F L, Delf Schmidt, P Nambi, et al.. (1987). A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.. PubMed. 31(3). 267–72. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact